Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808138Aexternal-prioritypatent/GB8808138D0/en
Application filed by Leo Pharm Prod LtdfiledCriticalLeo Pharm Prod Ltd
Priority to DK197590ApriorityCriticalpatent/DK169677B1/en
Publication of DK197590ApublicationCriticalpatent/DK197590A/en
Publication of DK197590D0publicationCriticalpatent/DK197590D0/en
Application grantedgrantedCritical
Publication of DK169677B1publicationCriticalpatent/DK169677B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
N-heterocyclic propylidene-1,1-bisphosphonic acids and salts thereof, their preparation, a pharmaceutical preparation The present invention relates to compounds of the formula (I) <IMAGE> in which R1-R8 can be identical or different and denote hydrogen or a straight-chain or branched aliphatic C1-C10 hydrocarbon group. R3 can also, together with either R1 or R5, form a saturated aliphatic 5-, 6- or 7-membered ring which can be substituted by one or more C1-C4-alkyl groups. The compounds of the formula I, which can be used in human and veterinary practice, act on bone metabolism.
DK197590A1988-04-071990-08-20New n-heterocyclic propylidene-1,1-bis:phosphonic acids - useful as drugs influencing calcium metabolism for treating arthritic disorders, atherosclerosis etc.
DK169677B1
(en)
New n-heterocyclic propylidene-1,1-bis:phosphonic acids - useful as drugs influencing calcium metabolism for treating arthritic disorders, atherosclerosis etc.
New n-heterocyclic propylidene-1,1-bis:phosphonic acids - useful as drugs influencing calcium metabolism for treating arthritic disorders, atherosclerosis etc.
New n-heterocyclic propylidene-1,1-bis:phosphonic acids - useful as drugs influencing calcium metabolism for treating arthritic disorders, atherosclerosis etc.